Abbott Laboratories (Pakistan) (KAR:ABOT) FCF Yield %: 6.57 (As of Jun. 30, 2026) — 174% Above Median


KAR:ABOT Abbott Laboratories (Pakistan) Ltd KAR:ABOT
77 GF Score
Price ₨970.76
GF Value ₨1,001.38
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Abbott Laboratories (Pakistan) FCF Yield %?

Abbott Laboratories (Pakistan) KAR:ABOT +0.45% 77 FCF Yield % is 6.57 as of Jun. 30, 2026, which is 174% above its 10-year median of 2.40. GuruFocus rates KAR:ABOT with a GF Score™ of 77/100 and a GF Value™ of ₨1,001.38 (Fairly Valued). The stock has 2 warning signs investors should review. Among 1,001 Drug Manufacturers companies, Abbott Laboratories (Pakistan) ranks better than 79.12% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Abbott Laboratories (Pakistan)'s Trailing 12-Month Free Cash Flow is ₨6,249 Mil, and Market Cap is ₨95,038 Mil. Therefore, Abbott Laboratories (Pakistan)'s FCF Yield % for today is 6.57%.

The historical rank and industry rank for Abbott Laboratories (Pakistan)'s FCF Yield % or its related term are showing as below:

KAR:ABOT' s FCF Yield % Range Over the Past 10 Years
Min: -16.64   Med: 2.4   Max: 10.8
Current: 6.57


During the past 13 years, the highest FCF Yield % of Abbott Laboratories (Pakistan) was 10.80%. The lowest was -16.64%. And the median was 2.40%.

KAR:ABOT's FCF Yield % is ranked better than
79.12% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 0.65 vs KAR:ABOT: 6.57

Abbott Laboratories (Pakistan)'s FCF Margin % for the quarter that ended in Mar. 2026 was -5.84%.


Abbott Laboratories (Pakistan) FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Abbott Laboratories (Pakistan) FCF Yield % Related Terms


Abbott Laboratories (Pakistan) FCF Yield % Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories (Pakistan)'s FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories (Pakistan) FCF Yield % Chart

Abbott Laboratories (Pakistan) Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.20 0.47 -6.96 1.36 7.24

Abbott Laboratories (Pakistan) Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.59 5.40 5.52 16.69 -4.77

KAR:ABOT vs ZTS, UTHR, VTRS: FCF Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Abbott Laboratories (Pakistan)'s FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories (Pakistan) FCF Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott Laboratories (Pakistan)'s FCF Yield % distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories (Pakistan)'s FCF Yield % falls into.


KAR:ABOT
77GF Score
Abbott Laboratories (Pakistan) Ltd KAR:ABOT
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories (Pakistan) FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Abbott Laboratories (Pakistan)'s FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=7441.279 / 102808.706
=7.24%

Abbott Laboratories (Pakistan)'s annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-1034.349 * 4 / 86818.699
=-4.77%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of 6.57 mean?
Abbott Laboratories (Pakistan) (KAR:ABOT) has a FCF Yield % of 6.57 as of Jun. 30, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Abbott Laboratories (Pakistan) and its competitors. This is 174% above median its historical median of 2.40. According to the industry distribution chart, Abbott Laboratories (Pakistan) ranks #209 out of 1001 companies in the Drug Manufacturers industry, placing it in the top 20.9%.
Is Abbott Laboratories (Pakistan)'s FCF Yield % too high?
Abbott Laboratories (Pakistan)'s current FCF Yield % of 6.57 is 174% above median its 10-year median of 2.40. The Drug Manufacturers industry median FCF Yield % is 0.65. Abbott Laboratories (Pakistan)'s value of 6.57 is 910.8% above this industry median. Based on the distribution chart, Abbott Laboratories (Pakistan) ranks #209 out of 1001 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Abbott Laboratories (Pakistan) has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories (Pakistan)'s FCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Abbott Laboratories (Pakistan) ranks #209 out of 1001 companies for FCF Yield %. This places Abbott Laboratories (Pakistan) in the top 21% of its industry — outperforming the majority of peers. The industry median FCF Yield % is 0.65. Abbott Laboratories (Pakistan)'s value of 6.57 is 910.8% above this benchmark. While the company's 10-year median is 2.40 vs. the industry median of 0.65, Abbott Laboratories (Pakistan) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.65, based on 1,001 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Abbott Laboratories (Pakistan)'s current FCF Yield % of 6.57 is 910.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Abbott Laboratories (Pakistan) and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abbott Laboratories (Pakistan)'s current FCF Yield % is 6.57, which is 174% above median its own 10-year median of 2.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories (Pakistan) stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (Pakistan) (KAR:ABOT) is currently considered Fairly Valued. The stock's GF Value™ is ₨1,001.38, compared to a current price of ₨970.76 — trading 3.1% below its estimated fair value. The current FCF Yield % is 6.57, which is 174% above median its 10-year median of 2.40 and 910.8% above the Drug Manufacturers industry median of 0.65. Abbott Laboratories (Pakistan)'s overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Abbott Laboratories (Pakistan) (KAR:ABOT), the current FCF Yield % is 6.57 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (Pakistan) (KAR:ABOT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories (Pakistan) stock appears to be undervalued. The current stock price of ₨970.76 is trading 3.1% below its estimated GF Value™ of ₨1,001.38. GuruFocus considers Abbott Laboratories (Pakistan) to be Fairly Valued.

Key valuation signals for KAR:ABOT:

  • FCF Yield %: 6.57 (174% above median its 10-year median of 2.40)
  • GF Value™: ₨1,001.38 vs. price of ₨970.76 (3.1% below fair value)
  • GF Score™: 77/100 with 2 warning signs
  • Industry Position: 910.8% above the Drug Manufacturers median (#209 of 1001)

No single metric tells the full story. See the KAR:ABOT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Abbott Laboratories (Pakistan) Business Description

Address Hyderabad Road, Landhi, P.O. Box 7229, Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Karachi, PAK, 75120
Abbott Laboratories (Pakistan) Ltd manufactures, imports, and markets research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. The company's Brands include Duphaston, Brufen, Surbex Z, Arinac, Glucerna, Pediasure, and Ensure.
77GF Score

Get the complete analysis for KAR:ABOT

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨970.76
Price
₨1,001.38
GF Value